Kristine A. Gordon - Concepedia

Concepedia

Author

Kristine A. Gordon

Seagen (United States)

Also Known As

K A Gordon, Kristine A. Gordon, Kristine Gordon

47

Publications

2.3K

Citations

15

H-Index

27

Concepts

All Affiliations

Seagen (United States)The University of Texas MD Anderson Cancer Center Vrije Universiteit Amsterdam Molecular Oncology (United States)

KA

About

Kristine A. Gordon is an author at Seagen (United States) specializing in immunotherapy, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	351
2	Cell Biology	3	3	291
3	Natural Sciences	1	1	60
4	Biochemistry	1	1	60
5	Biomolecular Engineering	1	1	60

Kristine A. Gordon

×

15

Publications

2.3K

Citations

15

H-Index

	Year	Citations
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity Joseph A. Francisco, Charles G. Cerveny, Damon L. Meyer, Blood	2003	907
Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates May S.K. Sutherland, Russell J. Sanderson, Kristine A. Gordon, Journal of Biological Chemistry	2006	291
Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates Che-Leung Law, Kristine A. Gordon, Brian E. Toki, Cancer Research Advanced Rcc PatientsImmunologyImmunotherapyAnti-cd70 Antibody-drug ConjugatesTumor Biology	2006	150
Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40 Che‐Leung Law, Kristine A. Gordon, J.M. Collier, Cancer Research ImmunologyPathologyAntigen ProcessingImmunotherapyHematological Malignancy	2005	124
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30 Ezogelin Oflazoglu, Ivan J. Stone, Kristine A. Gordon, Blood	2007	117
Efficient Elimination of B-Lineage Lymphomas by Anti-CD20–Auristatin Conjugates Che‐Leung Law, Charles G. Cerveny, Kristine A. Gordon, Clinical Cancer Research	2004	116
Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker Ezogelin Oflazoglu, Ivan J. Stone, Kristine A. Gordon, Clinical Cancer Research	2008	114
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco, Blood	2006	100
Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates Scott C. Jeffrey, Michael Torgov, Jamie B. Andreyka, Journal of Medicinal Chemistry	2005	89
Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40 Ezogelin Oflazoglu, Ivan J. Stone, Lindsay L. Brown, British Journal of Cancer	2008	79

Page 1